Hyperinflation: Clinical Trials

8 trials for Hyperinflation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 2 recruiting, 1 active not recruiting. 3 Not applicable, 3 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable3Completed 2, Recruiting 1
Phase 43Active not recruiting 1, Completed 1, Recruiting 1

Follow Hyperinflation: new trials by email Literature Review of Hyperinflation trials Research Report on Hyperinflation

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Investigate the Effect of Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Compared With Placebo MDI on Heart and Lung Function in Participants With Chronic Obstructive Pulmonary Disease (COPD) and Hyperinflation
Budesonide/Glycopyrronium/Formoterol Fumarate, Placebo, Metered dose inhaler - Chronic Obstructive Pulmonary Disease, Hyperinflation
Phase 4RecruitingAstraZeneca562025-11-242026-09-18
Effect of Elastic Chest Compression on Functional Exercise Capacity and Respiratory Performance in Patients With COPD
Theraband chest compression - COPD, Hyperinflation
Not applicableRecruitingNational Taiwan University Hospital172024-07-102024-07-25
4D Medical X-ray Velocimetry for Bronchoscopic Lung Volume Reduction Targeting
4D X-ray Velocimetry - Copd, Emphysema
CompletedVanderbilt University Medical Center172021-01-072024-06-21
Secondhand Smoke Respiratory Health Study
Albuterol, Placebo - Secondhand Smoke, Air Trapping
Phase 4Active not recruitingUniversity of California, San Francisco1072016-06-062026-06-04
Bronchial Thermoplasty for Severe Asthma With Dynamic Hyperinflation
Bronchial thermoplasty for treatment of severe asthma - Asthma, Hyperinflation
Not applicableCompletedUniversity Hospital, Toulouse142015-11-012026-05-29
Electrical Impedance Imaging of Patients on Mechanical Ventilation
Mechanical Ventilation, CT Scan - Pneumothorax, Pulmonary Contusion
CompletedColorado State University22014-09-012017-02-01
Acute Effect of Pulmonary Desufflation on Cardiac Performance in COPD Patients
Indacaterol Fumarate, Placebo - COPD, Hyperinflation
Phase 4CompletedUniversity of Milan402013-11-012014-11-13
Device-guided Breathing for Shortness of Breath in COPD
Twice daily practice of device-guided slow breathing. - COPD, Dyspnea
Not applicableCompletedMayo Clinic112011-01-012013-04-04

Narrower conditions

Pulmonary Disease, Chronic Obstructive (5)  ·  Emphysema (2)  ·  Asthma (1)  ·  Dyspnea (1)  ·  Lung Diseases, Obstructive (1)  ·  Pleural Effusion (1)  ·  Pneumothorax (1)  ·  Pulmonary Atelectasis (1)  ·  Pulmonary Edema (1)  ·  Pulmonary Heart Disease (1)  ·  Respiratory Distress Syndrome (1)

Broader conditions

Lung Diseases (8)  ·  Respiratory Tract Diseases (8)  ·  Lung Diseases, Obstructive (6)  ·  Pathologic Processes (6)  ·  Pathological Conditions, Signs and Symptoms (6)  ·  Chronic Disease (5)  ·  Disease Attributes (5)  ·  Respiration Disorders (2)  ·  Bronchial Diseases (1)  ·  Cardiovascular Diseases (1)  ·  Heart Diseases (1)  ·  Hypersensitivity (1)  ·  Hypersensitivity, Immediate (1)  ·  Immune System Diseases (1)  ·  Pleural Diseases (1)

Interventions

Albuterol (1)  ·  Bronchial Thermoplasty (1)  ·  Budesonide (1)  ·  Fructose (1)  ·  Metered Dose Inhalers (1)  ·  Procaterol (1)  ·  Respiration, Artificial (1)  ·  Tomography, X-Ray Computed (1)

Sponsors

AstraZeneca (1)  ·  Colorado State University (1)  ·  Mayo Clinic (1)  ·  National Taiwan University Hospital (1)  ·  University Hospital, Toulouse (1)  ·  University of California, San Francisco (1)  ·  University of Milan (1)  ·  Vanderbilt University Medical Center (1)

Countries

United States (4)  ·  France (1)  ·  Germany (1)  ·  Italy (1)  ·  Taiwan (1)  ·  United Kingdom (1)

Top investigators

Jennifer L Mueller, Ph.D. (1)  ·  Mehrdad Arjomandi, MD (1)  ·  Pierachille Santus, Md, PhD (1)  ·  Roberto Benzo, MD (1)

Results publications

PMID 32817006, PMID 42492489

NIH funding

2025 (1), R21EB016869 (1)